000 01863nam  2200421zi 4500
0019.935928
003CaOODSP
00520240509095727
006m     o  d f      
007cr mn|||||||||
008240325t20242024quca    ob   f000 0 eng d
020 |a9780660709871
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aEn84-373/2024E-PDF
24500|aAssessment : |bpiperazine.
24610|aPiperazine
264 1|aGatineau, QC : |bGovernment of Canada = Gouvernement du Canada, |c2024.
264 4|c©2024
300 |a1 online resource (iii, 19 pages) : |billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"May 2024."
500 |aIssued also in French under title: Évaluation : pipérazine.
500 |a"Chemical Abstracts Service Registry Number 110-85-0."
500 |aIssued by Environment and Climate Change Canada, Health Canada.
504 |aIncludes bibliographical references (pages 12-14).
520 |a"Pursuant to section 68 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted an assessment of piperazine. The Chemical Abstracts Service Registry (CAS RN for piperazine is 110-85-0"--Synopsis, page i.
650 0|aPiperazine|xRisk assessment|zCanada.
650 0|aPiperazine|xEnvironmental aspects|zCanada.
650 0|aPiperazine|xHealth aspects|zCanada.
650 0|aPiperazine|xToxicology.
7101 |aCanada. |bEnvironment and Climate Change Canada, |eissuing body.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tÉvaluation : |w(CaOODSP)9.935929
85640|qPDF|s312 KB|uhttps://publications.gc.ca/collections/collection_2024/eccc/En84-373-2024-eng.pdf